Physician profile
Jason D Wolf
NPI 1962755165
$7,353.21
in general payments reported to CMS, 2019-2025
39 companies · $1,538 in 2025
The $1,538 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $286 · 2021: $701 · 2022: $2,394 · 2023: $962 · 2024: $616 · 2025: $1,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,048 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,048.46 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,084.39 | 2022-2024 | Aquabeam System |
| Janssen Biotech, INC. | $589.12 | 2019-2025 | Erleada, Akeega |
| Coloplast Corp | $586.98 | 2019-2025 | Speedicath, Titan |
| Astellas Pharma US INC | $554.06 | 2019-2024 | Myrbetriq |
| Medtronic, INC. | $475.27 | 2021-2024 | Interstim |
| Rochester Medical Corporation | $394.04 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $353.24 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $318.63 | 2021-2024 | Prolaris |
| Boston Scientific Corporation | $307.85 | 2021-2025 | Ams 700, General - Erectile Dysfunction |
| Axonics, INC. | $306.82 | 2021-2024 | Axonics |
| Abbvie INC. | $273.19 | 2019-2025 | Botox |
| Pfizer INC. | $239.35 | 2022-2025 | |
| Neotract INC. | $215.79 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $189.02 | 2019-2023 | Xiaflex |
| Teleflex LLC | $161.17 | 2023-2025 | Urolift, Barrigel |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $148.51 | 2025 | |
| Urovant Sciences INC | $134.27 | 2021-2022 | |
| 180 Medical, INC. | $134.01 | 2019-2025 | Gentlecath Glide, Gentlecath |
| Endo USA, INC. | $96.55 | 2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $96.02 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $86.62 | 2022-2024 | Trelstar, Tlando |
| Tolmar, INC. | $67.01 | 2023-2024 | |
| Allergan, INC. | $60.35 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $58.45 | 2025 | Adstiladrin |
| Myovant Sciences INC. | $51.34 | 2022 | |
| Abc Home Medical Supply, INC. | $43.17 | 2022 | |
| Bluewind Medical | $41.40 | 2025 | Revi |
| Medtronic USA, INC. | $38.97 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $33.15 | 2022-2023 | Seglentis |
| Isoray, INC | $32.07 | 2023 | Brachytherapy Source |
| Astrazeneca Pharmaceuticals LP | $30.33 | 2025 | Airsupra |
| Ambu INC. | $23.39 | 2025 | |
| Halozyme INC | $23.27 | 2023 | |
| Biotissue Holdings INC. | $21.39 | 2025 | |
| Philips North America LLC | $20.40 | 2025 | Uronav |
| Olympus America INC. | $18.88 | 2022 | |
| Immunitybio, INC. | $18.04 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.40 | 2024 | |
| Laborie Medical Technologies Corp. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.